1 MG RP LILRA2
|
Invitrogen Human LILRA2 (CD85h, ILT1) Fc Chimera Recombinant Protein, Quantity: 1 mg,0,0,0,0, Accession Number: Q8N149,0,0,0,0, Endotoxin Concentration: <1.0 EU/ ug,0,0,0,0, Expression System: HEK293 cells,0,0,0,0, Format: Lyophilized,0,0,0,0, Formul
|
3136-RP88114
|
EA
|
|
100 UG RP LILRA2
|
Invitrogen Human LILRA2 (CD85h, ILT1) His-tag Recombinant Protein, Quantity: 100 ug,0,0,0,0, Accession Number: Q8N149,0,0,0,0, Endotoxin Concentration: <1.0 EU/ ug,0,0,0,0, Expression System: HEK293 cells,0,0,0,0, Format: Lyophilized,0,0,0,0, Formula
|
3136-RP88111
|
EA
|
|
100 UG RP LILRA2
|
Invitrogen Human LILRA2 (CD85h, ILT1) Fc Chimera Recombinant Protein, Quantity: 100 ug,0,0,0,0, Accession Number: Q8N149,0,0,0,0, Endotoxin Concentration: <1.0 EU/ ug,0,0,0,0, Expression System: HEK293 cells,0,0,0,0, Format: Lyophilized,0,0,0,0, Form
|
3136-RP88113
|
EA
|
|
1 MG RP CD52
|
Invitrogen Human CD52 Fc Chimera Recombinant Protein, Quantity: 1 mg,0,0,0,0, Accession Number: P31358,0,0,0,0, Endotoxin Concentration: <1.0 EU/ ug,0,0,0,0, Expression System: HEK293 cells,0,0,0,0, Format: Lyophilized,0,0,0,0, Formulation: PBS with
|
3136-RP88009
|
EA
|
|
1 MG RP CD79A
|
Invitrogen Human CD79a His-tag Recombinant Protein, Quantity: 1 mg,0,0,0,0, Accession Number: P11912,0,0,0,0, Endotoxin Concentration: <1.0 EU/ ug,0,0,0,0, Expression System: HEK293 cells,0,0,0,0, Format: Lyophilized,0,0,0,0, Formulation: PBS with 0.
|
3136-RP88017
|
EA
|
|